Skip to main content
Karen Lu, MD, Obstetrics & Gynecology, Houston, TX, University of Texas M.D. Anderson Cancer Center

KarenH.LuMD

Obstetrics & Gynecology Houston, TX

Gynecologic Oncology

Professor and Chair

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lu's full profile

Already have an account?

Education & Training

  • Brigham and Women’s Hospital
    Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 1996 - 1999
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1991 - 1995
  • Yale School of Medicine
    Yale School of MedicineClass of 1991

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 1999 - 2026
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • OK State Medical License
    OK State Medical License 2023 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • AZ State Medical License
    AZ State Medical License 2023 - 2024
  • GA State Medical License
    GA State Medical License 2023 - 2024
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer Susceptibility  
    Julie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, Karen Lu, Kunle Odunsi, Beth Y Karlan, Christine S Walsh, Douglas A Levine, Andrew Berchuck, Da..., PLoS One
  • KMT2D/MLL2 Inactivation Is Associated with Recurrence in Adult-Type Granulosa Cell Tumors of the Ovary  
    R Tyler Hillman, Karen H Lu, David M Gershenson, Nature
  • Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer  
    Samuel C Mok, Karen H Lu, Journal of the National Cancer Institute

Lectures

  • Women's Health 2013: The 21st Annual Congress 
    Academy of Women's Health, Washington, Dist Of Col - 3/22/2013

Other

Press Mentions

  • AACR Announces Recipients of Its 2022 Scientific Achievement Awards and Lectureships
    AACR Announces Recipients of Its 2022 Scientific Achievement Awards and LectureshipsApril 4th, 2022
  • Trials Test New Approach to Hereditary Ovarian Ca Risk Reduction
    Trials Test New Approach to Hereditary Ovarian Ca Risk ReductionMarch 20th, 2019
  • Scientists Detect New Ovarian Cancer Target
    Scientists Detect New Ovarian Cancer TargetJune 14th, 2018
  • Join now to see all

Grant Support

  • Training Of Academic Gynecologic OncologistsNational Cancer Institute2011
  • Metformin For The Chemoprevention Of Endometrial Cancer In Obese, Insulin-ResistaNational Cancer Institute2010–2011
  • M.D. Anderson Gynecologic Spore For Uterine CancersNational Cancer Institute2010–2011
  • Administrative CoreNational Cancer Institute2010–2011
  • Annual Uterine Cancer Biology SymposiumNational Cancer Institute2010
  • MD Anderson Cancer Ctr. Gynecology SPORE: Uterine CancerNational Cancer Institute2007–2009
  • Annual Uterine Cancer SymposiumNational Cancer Institute2004–2008
  • Phase II Clinical Trail - An Exploratory Study To IdentiDivision Of Cancer Prevention And Control2000

Professional Memberships

Hospital Affiliations